|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.79(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,171 |
8,648 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2018-02-10 |
4 |
D |
$42.94 |
$28,813 |
D/D |
(671) |
2,598 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
3,269 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,670 |
23,911 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2018-02-10 |
4 |
D |
$42.94 |
$21,771 |
D/D |
(507) |
9,085 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,469 |
9,592 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-02-10 |
4 |
D |
$42.94 |
$136,420 |
D/D |
(3,177) |
279,339 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,408 |
282,516 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2018-02-10 |
4 |
D |
$42.94 |
$39,762 |
D/D |
(926) |
1,477 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
2,403 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2018-02-10 |
4 |
D |
$42.94 |
$36,113 |
D/D |
(841) |
40,032 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
40,873 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2018-02-10 |
4 |
D |
$42.94 |
$36,070 |
D/D |
(840) |
5,992 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2018-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
6,832 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2018-02-05 |
4 |
D |
$43.58 |
$11,026 |
D/D |
(253) |
8,123 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
734 |
8,376 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,334 |
21,241 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2018-02-05 |
4 |
D |
$43.58 |
$21,354 |
D/D |
(490) |
4,429 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
4,919 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2018-02-05 |
4 |
D |
$43.58 |
$21,354 |
D/D |
(490) |
38,470 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
38,960 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-02-05 |
4 |
D |
$43.58 |
$69,205 |
D/D |
(1,588) |
276,108 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,203 |
277,696 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-01-31 |
4 |
S |
$46.06 |
$552,720 |
D/D |
(12,000) |
274,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-01-31 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
286,493 |
|
- |
|
1127 Records found
|
|
Page 21 of 46 |
|
|